Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-22

Clinical Trial Update: Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating hypofractionated radiotherapy followed by sequential chemotherapy for marginally resectable soft tissue sarcomas of the extrem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology | Conditions: Sarcoma, Fibrosarcoma | Phase 2 | Status: UNKNOWN